Cite
ZBTB5 enhances the resistance of cervical cancer to paclitaxel by regulating BCL6
MLA
Yue He, et al. ZBTB5 Enhances the Resistance of Cervical Cancer to Paclitaxel by Regulating BCL6. Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0fcfe91feb1883264b4b54f5f0b12325&authtype=sso&custid=ns315887.
APA
Yue He, Jing-Jing Zhang, Jian-Qing Xu, Yun-Fan Wang, Chen Ji, Yang Liu, Su-Bin Han, Ming Wang, Yan Wang, & Yu-Mei Wu. (2023). ZBTB5 enhances the resistance of cervical cancer to paclitaxel by regulating BCL6.
Chicago
Yue He, Jing-Jing Zhang, Jian-Qing Xu, Yun-Fan Wang, Chen Ji, Yang Liu, Su-Bin Han, Ming Wang, Yan Wang, and Yu-Mei Wu. 2023. “ZBTB5 Enhances the Resistance of Cervical Cancer to Paclitaxel by Regulating BCL6,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0fcfe91feb1883264b4b54f5f0b12325&authtype=sso&custid=ns315887.